Back to News
Market Impact: 0.5

SpaceX Stock: 3 Reasons I Am Not Buying the Dip

Artificial IntelligenceCapital Returns (Dividends / Buybacks)Corporate EarningsM&A & RestructuringCompany FundamentalsInvestor Sentiment & Positioning
SpaceX Stock: 3 Reasons I Am Not Buying the Dip

SpaceX shares are already down 20% since the IPO price and 52% from the all-time high after a Q2 earnings update that disappointed the market. Despite revenue rising 92% YoY to $7.8B and net loss cutting to $541M (from ~$1.0B), the article flags very heavy AI-related capex of $15.8B in Q2 (up more than 2x QoQ) and an all-stock $60B acquisition of Cursor that will dilute shareholders. With P/S at 73.4 versus a “reasonable” range below 2 and an Aug. 6 lockup expiration looming, the author expects further downside and highlights that returns on AI spending are unlikely over the next year.

Analysis

The market is likely extrapolating a financing story, not a fundamentals story. A high-multiple company issuing stock into a large AI capex program creates a reflexive loop: every dollar of “strategic investment” now carries an equity dilution cost, so the burden of proof shifts to near-term monetization. That is bad for SPCX, but also a warning shot for any pre-profit AI narrative that relies on future optionality instead of visible cash conversion.

The immediate overhang is supply, not demand. A first lockup window plus an all-stock acquisition raises the odds of incremental float hitting a market that already knows the story is crowded; that typically suppresses upside for 1-3 months even if the business is improving underneath. The more important catalyst is the next two quarters: if management cannot narrow losses while continuing to spend aggressively, the market will start haircutting the long-dated AI option value rather than paying for it.

Contrarian view: the consensus may be underweighting strategic scarcity value. If AI spend is truly building a differentiated network or launch/cost advantage, the current drawdown could be a classic “capex misread” where near-term ROIC looks awful but the asset base compounds for years. What would falsify the bearish thesis is any evidence that AI spend is decelerating, post-lockup insider supply is minimal, or operating leverage arrives faster than expected; absent that, the stock likely remains a financing overhang rather than a fundamentals story.

More News